Noom vs Virta Health

Side-by-side comparison of model-estimated upside.

Noom

+25%

est. 2Y upside i

HealthcareSeries D+

Rank

#1489

Sector

Digital Health, Healthcare Technology

Est. Liquidity

~2Y

Data Quality

Data: Medium

Noom offers a moderate expected upside of ~25% over 2 years, but with significant downside risk from stale valuation and fierce competition.

Last updated: July 19, 2026

Virta Health

-16%

est. 2Y upside i

HealthcareSeries D+

Rank

#2757

Sector

HealthTech

Est. Liquidity

~4Y

Data Quality

Data: Medium

Given a stale $2B valuation from 2021, high preference overhang, and likely near-term dilution, the expected 2-year return for common stock is -16.1%.

Last updated: July 19, 2026

Note: These companies have different risk levels. Noom (Moderate Risk) and Virta Health (Higher Risk). A higher expected upside in a higher-risk company comes with greater uncertainty. Compare within the same risk tier for more meaningful evaluation.

Upside Comparison

Expected Upside

Disclaimer: These rankings are AI-generated estimates and do not constitute financial or career advice. Always conduct your own due diligence.